<DOC>
	<DOCNO>NCT00856713</DOCNO>
	<brief_summary>A study healthy volunteer patient liver cirrhosis ass effect age , gender , stable liver disease clearance cholyl-lysyl-fluorescein ( NRL972 )</brief_summary>
	<brief_title>Clearance NRL972 Patients With Cirrhosis Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Subjects meet follow condition eligible enrolment : General subject 1 . Males female ( female nonchildbearing potential childbearing potential take medically appropriate contraception ) 2 . Caucasian 3 . BMI : 19 34 kg.m2 4 . BW : 45 110 kg 5. willing able provide inform consent Healthy volunteer ( group N ) 6 . Age : 18 40 year ( inclusive ) &gt; 60 year 7 . Assessed healthy base prestudy examination Hepatic cirrhosis 8 . Age : 18 75 year 9. stable compensate liver cirrhosis ( cryptogenic , posthepatic , alcoholic ) histological macroscopic ( e.g . laparascopy , biopsy , ultrasound sonography adequate imaging technique ) confirmation Subjects follow category exclude enrolment : General subject 1 . Previous participation trial 2 . Participant trial last 90 day 3 . Donation blood last 60 day history blood loss exceed 300 mL within last 3 month 4 . History clinically relevant allergy 5 . Presence acute chronic infection 6 . Uncontrolled diabetes mellitus 7 . Resting systolic blood pressure &gt; 160 &lt; 90 mmHg , diastolic blood pressure &gt; 95 &lt; 50 mmHg 8 . Clinically relevant ECGabnormalities , prolong QTc &gt; 450 msec male &gt; 460 msec female particular 9 . Positive HIV test 10 . Positive alcohol urine drug test recruitment 11 . Daily use &gt; 30 gr alcohol 12 . Smoking 15 cigarettes/day equivalent tobacco product 13 . Use prohibit medication 14 . Suspicion evidence subject trustworthy reliable 15 . Suspicion evidence subject able make free consent understand information regard General females 16 . Positive pregnancy test 17 . Lactating 18 . Not use appropriate contraception premenopausal woman All healthy subject 19 . Presence history relevant comorbidity 20 . Presence relevant abnormality laboratory safety test , especially low Hemoglobin , increase liver enzymes , reduce serum creatinine 21 . Positive serology HBsAg , anti HBc anti HCV 22 . History alcohol and/or drug abuse Patients hepatic disease 23 . Biliary liver cirrhosis 24 . Liver impairment due spaceoccupying process ( e.g . carcinoma ) 25 . State liver transplantation patient schedule liver transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>